• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成功对患有结节性硬化症胎儿的心脏横纹肌瘤进行产前治疗。

Successful Prenatal Treatment of Cardiac Rhabdomyoma in a Fetus with Tuberous Sclerosis.

作者信息

Will Joachim Carsten, Siedentopf Nina, Schmid Oliver, Gruber Teresa Mira, Henrich Wolfgang, Hertzberg Christoph, Weschke Bernhard

机构信息

Department of Pediatric Cardiology, 13353 Berlin, Germany.

Department of Obstetrics, 13353 Berlin, Germany.

出版信息

Pediatr Rep. 2023 Mar 22;15(1):245-253. doi: 10.3390/pediatric15010020.

DOI:10.3390/pediatric15010020
PMID:36976727
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10059978/
Abstract

Cardiac rhabdomyomas are a possible early manifestation of the Tuberous Sclerosis Complex (TSC). They often regress spontaneously but may grow and cause cardiac dysfunction, threatening the child's life. Treatment with rapalogs can stop the growth of these cardiac tumors and even make them shrink. Here, we present the case of a successful treatment of a cardiac rhabdomyoma in a fetus with TSC by administering sirolimus to the mother. The child's father carries a mutation and the family already had a child with TSC. After we confirmed the TSC diagnosis and growth of the tumor with impending heart failure, we started treatment at 27 weeks of gestation. Subsequently, the rhabdomyoma shrank and the ventricular function improved. The mother tolerated the treatment very well. Delivery was induced at 39 weeks and 1 day of gestation and proceeded without complications. The length, weight, and head circumference of the newborn were normal for the gestational age. Rapalog treatment was continued with everolimus. Metoprolol and vigabatrin were added because of ventricular preexcitation and epileptic discharges in the EEG, respectively. We provide the follow-up data on the child's development in her first two years of life and discuss the efficacy and safety of this treatment.

摘要

心脏横纹肌瘤是结节性硬化症(TSC)可能出现的早期表现。它们通常会自发消退,但也可能生长并导致心脏功能障碍,威胁儿童生命。使用雷帕霉素类似物治疗可以阻止这些心脏肿瘤的生长,甚至使其缩小。在此,我们报告一例通过给患有TSC的胎儿母亲使用西罗莫司成功治疗心脏横纹肌瘤的病例。孩子的父亲携带一种突变,且该家庭已有一个患有TSC的孩子。在我们确诊TSC并确认肿瘤生长且即将出现心力衰竭后,于妊娠27周开始治疗。随后,横纹肌瘤缩小,心室功能改善。母亲对治疗耐受性良好。在妊娠39周零1天引产,过程无并发症。新生儿的身长、体重和头围与孕周相符。继续使用依维莫司进行雷帕霉素类似物治疗。因心室预激分别加用美托洛尔,因脑电图出现癫痫放电加用vigabatrin。我们提供了该儿童出生后头两年的发育随访数据,并讨论了这种治疗方法的疗效和安全性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9105/10059978/536ac2010e45/pediatrrep-15-00020-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9105/10059978/891b99259e44/pediatrrep-15-00020-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9105/10059978/0c19f3a3793e/pediatrrep-15-00020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9105/10059978/bd9df60f10b8/pediatrrep-15-00020-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9105/10059978/536ac2010e45/pediatrrep-15-00020-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9105/10059978/891b99259e44/pediatrrep-15-00020-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9105/10059978/0c19f3a3793e/pediatrrep-15-00020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9105/10059978/bd9df60f10b8/pediatrrep-15-00020-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9105/10059978/536ac2010e45/pediatrrep-15-00020-g004.jpg

相似文献

1
Successful Prenatal Treatment of Cardiac Rhabdomyoma in a Fetus with Tuberous Sclerosis.成功对患有结节性硬化症胎儿的心脏横纹肌瘤进行产前治疗。
Pediatr Rep. 2023 Mar 22;15(1):245-253. doi: 10.3390/pediatric15010020.
2
Fetal cardiac tumor: echocardiography, clinical outcome and genetic analysis in 53 cases.胎儿心脏肿瘤:53 例病例的超声心动图、临床结果和遗传学分析。
Ultrasound Obstet Gynecol. 2019 Jul;54(1):103-109. doi: 10.1002/uog.19108. Epub 2019 Jun 12.
3
Regression of symptomatic multiple cardiac rhabdomyomas associated with tuberous sclerosis complex in a newborn receiving everolimus.接受依维莫司治疗的新生儿中,与结节性硬化症相关的有症状多发性心脏横纹肌瘤的消退。
J Trop Pediatr. 2015 Feb;61(1):74-7. doi: 10.1093/tropej/fmu056. Epub 2014 Oct 24.
4
Fetal Tuberous Sclerosis: Sirolimus for the Treatment of Fetal rhabdomyoma.胎儿结节性硬化症:西罗莫司治疗胎儿横纹肌瘤。
Fetal Pediatr Pathol. 2022 Oct;41(5):800-806. doi: 10.1080/15513815.2021.1948646. Epub 2021 Jul 19.
5
Rhabdomyomas and tuberous sclerosis complex: our experience in 33 cases.横纹肌瘤与结节性硬化症复合体:我们33例病例的经验
BMC Cardiovasc Disord. 2014 May 9;14:66. doi: 10.1186/1471-2261-14-66.
6
Antenatal screening and diagnosis of tuberous sclerosis complex by fetal echocardiography and targeted genomic sequencing.通过胎儿超声心动图和靶向基因组测序进行结节性硬化症复合体的产前筛查和诊断。
Medicine (Baltimore). 2018 Apr;97(15):e0112. doi: 10.1097/MD.0000000000010112.
7
Prenatal Sirolimus Treatment for Rhabdomyomas in Tuberous Sclerosis.产前西罗莫司治疗结节性硬化症中的横纹肌瘤。
Pediatr Neurol. 2021 Dec;125:26-31. doi: 10.1016/j.pediatrneurol.2021.09.014. Epub 2021 Sep 25.
8
Single giant mediastinal rhabdomyoma as a sole manifestation of TSC in foetus.单一巨大纵隔横纹肌瘤作为胎儿结节性硬化症的唯一表现。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017 Sep;161(3):326-329. doi: 10.5507/bp.2017.023. Epub 2017 Jun 12.
9
Detection of maternal transmission of a splicing mutation in the TSC2 gene following prenatal diagnosis of fetal cardiac rhabdomyomas mimicking congenital cystic adenomatoid malformation of the lung and cerebral tubers and awareness of a family history of maternal epilepsy.检测到 TSC2 基因剪接突变的母体传递,此前胎儿心脏横纹肌瘤的产前诊断类似于先天性肺囊性腺瘤样畸形和脑结节,且存在母体癫痫的家族史。
Taiwan J Obstet Gynecol. 2013 Sep;52(3):415-9. doi: 10.1016/j.tjog.2013.05.002.
10
Sirolimus therapy for fetal cardiac rhabdomyoma in a pregnant woman with tuberous sclerosis.西罗莫司治疗一名患有结节性硬化症孕妇的胎儿心脏横纹肌瘤。
Obstet Gynecol Sci. 2019 Jul;62(4):280-284. doi: 10.5468/ogs.2019.62.4.280. Epub 2019 Jun 21.

引用本文的文献

1
Drug review: mTOR-inhibitor therapy in fetal cardiac rhabdomyoma-a tightrope walk.药物综述:胎儿心脏横纹肌瘤的mTOR抑制剂治疗——如履薄冰。
Front Pediatr. 2025 Aug 26;13:1649341. doi: 10.3389/fped.2025.1649341. eCollection 2025.
2
Prenatal Diagnosis and Management of Tuberous Sclerosis Complex with Cardiac Rhabdomyoma: A Case Report Highlighting the Role of Sirolimus and Postnatal Complications.伴有心脏横纹肌瘤的结节性硬化症的产前诊断与管理:一例强调西罗莫司作用及产后并发症的病例报告
Diagnostics (Basel). 2025 Jul 18;15(14):1811. doi: 10.3390/diagnostics15141811.
3
Effective Sirolimus Use in Prenatal and Postnatal Management of Symptomatic Extensive Congenital Capillary-Lymphatic-Venous Malformations (CLVMs): A Report of Two Cases.

本文引用的文献

1
Prenatal Sirolimus Treatment for Rhabdomyomas in Tuberous Sclerosis.产前西罗莫司治疗结节性硬化症中的横纹肌瘤。
Pediatr Neurol. 2021 Dec;125:26-31. doi: 10.1016/j.pediatrneurol.2021.09.014. Epub 2021 Sep 25.
2
Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations.更新后的国际结节性硬化症复合体诊断标准及监测与管理建议。
Pediatr Neurol. 2021 Oct;123:50-66. doi: 10.1016/j.pediatrneurol.2021.07.011. Epub 2021 Jul 24.
3
Sirolimus in infants with congenital hyperinsulinism (CHI) - a single-centre experience.
西罗莫司在有症状的广泛性先天性毛细血管-淋巴管-静脉畸形(CLVMs)产前和产后管理中的有效应用:两例报告
Paediatr Drugs. 2025 Jul 6. doi: 10.1007/s40272-025-00708-3.
4
Transplacental sirolimus: a new treatment strategy for life-threatening fetal cardiac rhabdomyomas-a case report.经胎盘西罗莫司:一种治疗危及生命的胎儿心脏横纹肌瘤的新策略——病例报告
Orphanet J Rare Dis. 2025 Jun 9;20(1):291. doi: 10.1186/s13023-025-03780-7.
5
Foetal cardiac rhabdomyoma due to paternal Mutation: a case report and literature review.父系突变导致的胎儿心脏横纹肌瘤:一例报告及文献综述
Pathologica. 2025 Feb;117(1):33-38. doi: 10.32074/1591-951X-1099.
6
Cardiac Tumors Causing Sudden Cardiac Death: A State-of-the-Art Review in Pathology.导致心源性猝死的心脏肿瘤:病理学的最新综述
Cancers (Basel). 2025 Feb 17;17(4):669. doi: 10.3390/cancers17040669.
7
KaRhab: an international online registry for cardiac rhabdomyomas.KaRhab:一个用于心脏横纹肌瘤的国际在线登记处。
Orphanet J Rare Dis. 2025 Jan 30;20(1):44. doi: 10.1186/s13023-024-03470-w.
8
mTOR inhibitors as potential therapeutics for endometriosis: a narrative review.mTOR抑制剂作为子宫内膜异位症的潜在治疗方法:一项叙述性综述
Mol Hum Reprod. 2024 Dec 11;30(12). doi: 10.1093/molehr/gaae041.
9
mTOR inhibitors potentially preserve fertility in female patients with haematopoietic malignancies: a narrative review.mTOR抑制剂可能会保留造血系统恶性肿瘤女性患者的生育能力:一项叙述性综述。
Ann Hematol. 2024 Dec;103(12):4953-4969. doi: 10.1007/s00277-024-06090-3. Epub 2024 Nov 13.
10
Prenatal mTOR Inhibitors in Tuberous Sclerosis Complex: Current Insights and Future Directions.结节性硬化症中的产前mTOR抑制剂:当前见解与未来方向
J Clin Med. 2024 Oct 23;13(21):6335. doi: 10.3390/jcm13216335.
西罗莫司在婴儿先天性胰岛素过多症(CHI)中的应用——单中心经验。
Eur J Pediatr. 2022 Jan;181(1):407-412. doi: 10.1007/s00431-021-04209-6. Epub 2021 Jul 24.
4
Fetal Tuberous Sclerosis: Sirolimus for the Treatment of Fetal rhabdomyoma.胎儿结节性硬化症:西罗莫司治疗胎儿横纹肌瘤。
Fetal Pediatr Pathol. 2022 Oct;41(5):800-806. doi: 10.1080/15513815.2021.1948646. Epub 2021 Jul 19.
5
Birth-related subdural hemorrhage: prevalence and imaging morphology.与分娩相关的硬脑膜下血肿:患病率和影像学形态。
Pediatr Radiol. 2021 May;51(6):939-946. doi: 10.1007/s00247-021-05060-5. Epub 2021 Apr 8.
6
Echocardiography and Newer Imaging Techniques in Diagnosis and Long-Term Follow-Up of Primary Heart Tumors in Children.超声心动图及新的影像学技术在儿童原发性心脏肿瘤的诊断和长期随访中的应用。
Int J Environ Res Public Health. 2020 Jul 29;17(15):5471. doi: 10.3390/ijerph17155471.
7
TSC2 pathogenic variants are predictive of severe clinical manifestations in TSC infants: results of the EPISTOP study.TSC2 致病性变异与 TSC 婴儿严重临床表现相关:EPISTOP 研究结果。
Genet Med. 2020 Sep;22(9):1489-1497. doi: 10.1038/s41436-020-0823-4. Epub 2020 May 28.
8
Fetal cardiac rhabdomyomas treated with maternal sirolimus.胎儿心脏横纹肌瘤的母亲西罗莫司治疗。
Prenat Diagn. 2020 Feb;40(3):358-364. doi: 10.1002/pd.5613. Epub 2020 Jan 2.
9
Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review.西罗莫司治疗血管异常的疗效和安全性:系统评价。
J Vasc Surg. 2020 Jan;71(1):318-327. doi: 10.1016/j.jvs.2019.06.217. Epub 2019 Oct 30.
10
Sirolimus therapy for fetal cardiac rhabdomyoma in a pregnant woman with tuberous sclerosis.西罗莫司治疗一名患有结节性硬化症孕妇的胎儿心脏横纹肌瘤。
Obstet Gynecol Sci. 2019 Jul;62(4):280-284. doi: 10.5468/ogs.2019.62.4.280. Epub 2019 Jun 21.